<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01398098</url>
  </required_header>
  <id_info>
    <org_study_id>FCOL 111</org_study_id>
    <secondary_id>2011-002953-80</secondary_id>
    <nct_id>NCT01398098</nct_id>
  </id_info>
  <brief_title>Measurement of Gastric Emptying During and After COLOKIT® Intake</brief_title>
  <official_title>Gastric Emptying Time Assessment During Bowel Preparation With COLOKIT®</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Mayoly Spindler</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratoires Mayoly Spindler</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ultra-sound study to assess changes in intragastric volume after bowel preparation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with a residual antral volume lower than 20 mL</measure>
    <time_frame>after 2nd treatment regimen intake</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>After drug intake</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability of COLOKIT®.</measure>
    <time_frame>After drug intake</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Colonoscopy results</measure>
    <time_frame>After colonoscopy.</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>COLOKIT®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium phosphate</intervention_name>
    <description>32 tablets</description>
    <arm_group_label>COLOKIT®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject who signed an informed consent to participate in the trial.&#xD;
&#xD;
          -  Subject affiliated with Social Security&#xD;
&#xD;
          -  Men and women aged 18 to 75 years.&#xD;
&#xD;
          -  Subject with an indication of scheduled outpatient colonoscopy.&#xD;
&#xD;
          -  colonoscopy performed within six hours after the second sequence COLOKIT®.&#xD;
&#xD;
          -  Subject able to swallow tablets.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Women pregnant or likely to be (without contraception) or nursing.&#xD;
&#xD;
          2. Subject having any of the following diseases or conditions:&#xD;
&#xD;
               -  allergy or hypersensitivity to the product tested or any of its excipients,&#xD;
&#xD;
               -  nausea, vomiting or abdominal pain,&#xD;
&#xD;
               -  clinically significant renal failure,&#xD;
&#xD;
               -  primary hyperparathyroidism associated with hypercalcemia,&#xD;
&#xD;
               -  congestive heart failure,&#xD;
&#xD;
               -  ascites,&#xD;
&#xD;
               -  a known or suspected bowel obstruction,&#xD;
&#xD;
               -  megacolon (congenital or acquired)&#xD;
&#xD;
               -  intestinal perforation,&#xD;
&#xD;
               -  ileus,&#xD;
&#xD;
               -  an inflammatory disease or suspected inflammatory bowel disease,&#xD;
&#xD;
               -  swallowing disorders,&#xD;
&#xD;
               -  known digestive motor disorders (gastroparesis, scleroderma, mega-esophagus),&#xD;
&#xD;
               -  diabetes mellitus (insulin or non insulin-dependent)&#xD;
&#xD;
               -  a history of gastric surgery (partial or total)&#xD;
&#xD;
               -  a contraindication to the anesthesia required for the completion of the&#xD;
                  colonoscopy,&#xD;
&#xD;
               -  Any clinical condition which, in the opinion of the investigator, would not allow&#xD;
                  the subject to perform the test in good conditions.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stanislas CHAUSSADE, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cochin Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <study_first_submitted>July 13, 2011</study_first_submitted>
  <study_first_submitted_qc>July 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2011</study_first_posted>
  <last_update_submitted>November 28, 2012</last_update_submitted>
  <last_update_submitted_qc>November 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

